US EditionVariability of Comparator Drugs in Ex-US HTAs Offers Lessons for the IRA
Summary by avalerehealth.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Variability of Comparator Drugs in Ex-US HTAs Offers Lessons for the IRA
As a key component of the Medicare Drug Price Negotiation Program under the Inflation Reduction Act (IRA), the Centers for Medicare and Medicaid Services (CMS) compares products under negotiation with therapeutic alternatives to establish comparative benchmarks for safety, effectiveness, and cost. Across the globe, health technology assessment (HTA) bodies use comparative processes to inform decisions about product coverage, cost-effectiveness, …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
